Biotech

All Articles

' All hands on deck' at Lilly as peers target weight problems market

.CEO David Ricks can observe the providers putting together camping tents at basecamp behind Eli Lil...

Entero giving up personnel, vacating workplace as well as pausing R&ampD

.Bed mattress Liquidators has actually switched Entero Rehabs white as a piece. The financial instit...

Exelixis goes down ADC after deciding it's no suit for Tivdak

.Exelixis is actually giving up on its tissue factor (TF)- targeting antibody-drug conjugate after c...

Relay loses interest in SHP2 inhibitor after Genentech leaves

.Three weeks after Roche's Genentech device walked away from an SHP2 inhibitor contract, Relay Rehab...

Stoke's Dravet syndrome med launched of predisposed medical grip

.Stoke Therapeutics' Dravet syndrome medication has actually been actually freed from a predisposed ...

Fierce Biotech's Gabrielle Masson offers Tough 15 at NYSE

.Ferocious Biotech Affiliate Publisher Gabrielle Masson showed the 2024 lesson of Tough 15 winners o...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) development o...

Daiichi pays for Merck $170M to develop lung cancer cells T-cell engager deal

.Merck &amp Co. has actually swiftly gotten back several of the prices of its Harp on Therapeutics b...

BioMarin halts preclinical genetics treatment for heart disease

.After BioMarin carried out a springtime clean of its own pipeline in April, the provider has decide...

Eisai plants molecular glue SEED with $1.5 B biobucks deal

.Major Pharmas stay caught to the tip of molecular adhesive degraders. The current provider to view ...